The prices of more drugs to treat diseases like cancer and HIV infections have been further reduced by the National Pharmaceutical Pricing Authority (NPPA).

The rates have come down by between 10 per cent and 35 per cent in the latest exercise by the drug pricing authority.

Among the drugs which will become cheaper are Melphalan (2 and 5 mg) and Chlorambucil (2 mg) used in the treatment of various types of cancers, and doxycycline (100 mg) and Zidovudine (300 mg) and Lamivudine (150 mg). The latter two are used to treat HIV infections.

The regulatory measures introduced by the NPPA resulted in significant saving for patients over the last couple of years.


Guide to approaching a consumer court

India's first practical guide to resolving your complaints by approaching consumer court. Guidance
Customer Complaint


Enter your email address to subscribe to our Newsletter.